Table 3: Comparison of U.S. Colorectal Cancer
Screening Guidelines for Average Risk Individuals.
Recommendations |
Joint
Guideline:1 ACS US
Multi-Society Task Force2 American
College of Radiology March
2008 |
American
College of Gastroenterology3 December
2008 |
USPSTF4 2016 Draft
Recommendation |
Age
to Start Screening |
50
years |
50
years (45 years for black persons) |
50
years |
Age
to Stop Screening |
Stop
when curative therapy is not an option |
Not
addressed |
Individualize
decision between age 76 and 85 and stop screening after age 85 |
Colorectal
Cancer Detection Tests |
|||
gFOBT
or FIT |
Annually |
Annual
FIT is preferred CRC detection test for those who decline colonoscopy or
other CRC prevention test. Annual Hemoccult SENSA is an alternative CRC
detection test. |
Annually |
Multi-target
Stool DNA test |
Every
3 years |
Every
3 years as alternative to FIT for CRC detection |
Insufficient
evidence to recommend |
Colorectal
Cancer Prevention Tests |
|||
DCBE |
Every
5 years |
Replaced
by CT colonography |
Not
Addressed |
CT
Colonography |
Every
5 years |
Every
5 years as alternative to colonoscopy for CRC prevention |
Insufficient
evidence to recommend |
Flexible
Sigmoidoscopy |
Every
5 years with or without annual gFOBT or FIT |
Every
5 to 10 years as alternative to colonoscopy for CRC prevention |
Every
10 years together with annual FIT |
Colonoscopy |
Every
10 years |
Preferred
test every 10 years for CRC prevention |
Every
10 years |
1Any one of the
recommended tests is acceptable, but prevention of colorectal cancer is the
greater priority
2US Multi-Society Task
Force includes the American College of Gastroenterology, American
Gastroenterological Association, and the American Society for Gastrointestinal
Endoscopy
3Preferred strategy of
CRC preventive tests over CRC detection tests, with colonoscopy as preferred
test
4Any one of the
recommended tests is adequate
ACS:
American Cancer Society; USPSTF: United
States Preventive Services Task Force; gFOBT:
high sensitivity guaiac fecal occult blood test;
FIT: fecal immunochemical test; CRC: colorectal
cancer; DNA: deoxyribonucleic acid; DCBE:
double-contrast barium enema; CT: computed tomography